By contrast, KD of SLC25A43 resulted in a significant reduction of cytotoxic effects by 16 nM paclitaxel in the two breast cancer cell lines MCF7 and BT-474 compared to siCtrl (Fig. 1A). This evidence concerns the gene SLC25A43 and breast carcinoma.